The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Human cerebrospinal fluid monoclonal N -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis
Open accessAbstract
See Zekeridou and Lennon (doi: 10.1093/aww213 ) for a scientific commentary on this article . Anti- N -methyl-D-aspartate receptor (NMDAR) encephalitis is a recently discovered autoimmune syndrome associated with psychosis, dyskinesias, and seizures. Little is known about the cerebrospinal fluid autoantibody repertoire. Antibodies against the NR1 subunit of the NMDAR are thought to be pathogenic; however, direct proof is lacking as previous experiments could not distinguish the contribution of further anti-neuronal antibodies. Using single cell cloning of full-length immunoglobulin heavy and light chain genes, we generated a panel of recombinant monoclonal NR1 antibodies from cerebrospinal fluid memory B cells and antibody secreting cells of NMDAR encephalitis patients. Cells typically carried somatically mutated immunoglobulin genes and had undergone class-switching to immunoglobulin G, clonally expanded cells carried identical somatic hypermutation patterns. A fraction of NR1 antibodies were non-mutated, thus resembling ‘naturally occurring antibodies’ and indicating that tolerance induction against NMDAR was incomplete and somatic hypermutation not essential for functional antibodies. However, only a small percentage of cerebrospinal fluid-derived antibodies reacted against NR1. Instead, nearly all further antibodies bound specifically to diverse brain-expressed epitopes including neuronal surfaces, suggesting that a broad repertoire of antibody-secreting cells enrich in the central nervous system during encephalitis. Our functional data using primary hippocampal neurons indicate that human cerebrospinal fluid-derived monoclonal NR1 antibodies alone are sufficient to cause neuronal surface receptor downregulation and subsequent impairment of NMDAR-mediated currents, thus providing ultimate proof of antibody pathogenicity. The observed formation of immunological memory might be relevant for clinical relapses. See Zekeridou and Lennon (doi: 10.1093/aww213 ) for a scientific commentary on this article . Antibodies against the NR1 subunit of the NMDA receptor are suspected to underlie anti-NMDA receptor encephalitis. Kreye et al. provide direct evidence by showing that monoclonal human NR1 antibodies are sufficient to downregulate synaptic NMDA receptors. They show too that patients harbour a much broader auto-antibody repertoire than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Self-citationGresa-Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice-Gordon, R., Rosenfeld, M. R., Lynch, D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70282-5 · Cited by 1,306
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Self-citationDeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J. A., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin
Prüss, H., Dalmau, J., Harms, L., Höltje, M., Ahnert-Hilger, G., Borowski, K., Stoecker, W., & Wandinger, K. P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc2a06 · Cited by 631
Self-citationHuman N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Planagumà, J., Leypoldt, F., Mannara, F., Gutiérrez-Cuesta, J., Martín-García, E., Aguilar, E., Titulaer, M. J., Petit-Pedrol, M., Jain, A., Balice-Gordon, R., et al. (2015) · Brain · doi:10.1093/brain/awu310 · Cited by 489
Autoreactivity in Human IgG+ Memory B Cells
Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M. C., & Wardemann, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.009 · Cited by 478
Self-citationAnalysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
Martinez-Hernandez, E., Horvath, J., Shiloh-Malawsky, Y., Sangha, N., Martinez-Lage, M., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c136 · Cited by 375
Acute mechanisms underlying antibody effects in anti–N‐methyl‐D‐aspartate receptor encephalitis
Moscato, E. H., Peng, X., Jain, A., Parsons, T. D., Dalmau, J., & Balice‐Gordon, R. J. (2014) · Annals of Neurology · doi:10.1002/ana.24195 · Cited by 367
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Kabat, E. A., & Wu, T. T. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1709 · Cited by 333
Gleichman, A. J., Spruce, L. A., Dalmau, J., Seeholzer, S. H., & Lynch, D. R. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0064-12.2012 · Cited by 290
Corbett, S. J., Tomlinson, I. M., Sonnhammer, E. L. L., Buck, D., & Winter, G. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1141 · Cited by 282
Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology
Peery, H. E., Day, G. S., Dunn, S., Fritzler, M. J., Prüss, H., De Souza, C., Doja, A., Mossman, K., Resch, L., Xia, C., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.001 · Cited by 192
Self-citationHigh prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
Doss, S., Wandinger, K., Hyman, B. T., Panzer, J. A., Synofzik, M., Dickerson, B. C., Mollenhauer, B., Scherzer, C. R., Ivinson, A. J., Finke, C., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.120 · Cited by 150
Self-citationIgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment
Prüss, H., Höltje, M., Maier, N., Gomez, A., Buchert, R., Harms, L., Ahnert-Hilger, G., Schmitz, D., Terborg, C., Kopp, U., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318258300d · Cited by 143
Self-citationEpileptogenic effects of NMDAR antibodies in a passive transfer mouse model
Wright, S. K., Hashemi, K. S., Stasiak, L., Bartram, J., Lang, B., Vincent, A. C., & Upton, A. L. (2015) · Brain · doi:10.1093/brain/awv257 · Cited by 142
Abnormal Neurons in Teratomas in NMDAR Encephalitis
Day, G. S., Laiq, S., Tang‐Wai, D. F., & Muñoz, D. G. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.488 · Cited by 107
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
Deakin, J., Lennox, B., & Zandi, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.018 · Cited by 89
Trafficking of NMDA receptors during status epilepticus: Therapeutic implications
Wasterlain, C. G., Naylor, D. E., Liu, H., Niquet, J., & Baldwin, R. A. (2013) · Epilepsia · doi:10.1111/epi.12285 · Cited by 69
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut
Prüß, H., Leubner, J., Wenke, N. K., Czirják, G. Á., Szentiks, C. A., & Greenwood, A. D. (2015) · Scientific Reports · doi:10.1038/srep12805 · Cited by 64
Self-citationCerebrospinal fluid CD19+ B‐cell expansion in N‐methyl‐ D ‐aspartate receptor encephalitis
Dale, R. C., Pillai, S. C., & Brilot, F. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12036 · Cited by 38
Knockdown and overexpression of NR1 modulates NMDA receptor function
Kalev‐Zylinska, M. L., Symes, W., Young, D., & During, M. J. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.04.003 · Cited by 37
Cited by
Antibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329
Dalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30244-3 · Cited by 899
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Pollak, T. A., Lennox, B. R., Müller, S., Benros, M. E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30290-1 · Cited by 402
Self-citation
Metadata
- Authors
- Kreye, J., Wenke, N. K., Chayka, M., Leubner, J., Murugan, R., Maier, N., Jurek, B., Ly, L.-T., Brandl, D., Rost, B. R., Stumpf, A., Schulz, P., Radbruch, H., Hauser, A. E., Pache, F., Meisel, A., Harms, L., Paul, F., Dirnagl, U., Garner, C., Schmitz, D., Wardemann, H., & Prüss, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-08-20
- Volume
- 139
- Issue
- 10
- Pages
- 2641-2652
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2510204423
- Cited by
- 290
- References
- 27
- FWCI
- 19.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.